Impact of FDG-PET on therapy management and outcome of differentiated thyroid carcinoma patients with elevated thyroglobulin despite negative iodine scintigraphy.

CONCLUSION: The early use of FDG-PET imaging in cases of suspected recurrence or existence of dedifferentiated DTC can lead to changes in therapy management, specifically identifying patients unlikely to benefit from additional radioiodine therapy who would instead qualify for surgical therapy methods. PMID: 32542618 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32542618?dopt=Abstract

Source: Nuklearmedizin - June 14, 2020 Category: Radiology Authors: Schleupner MC, Riemann B, Schäfers M, Backhaus P, Vrachimis A Tags: Nuklearmedizin Source Type: research